Compounded GLP-1s are no longer to be sold following the FDA announcement that the shortage of semaglutide and tirzepatide ended.

It is not yet clear when that national security investigation will end, and if and how tariffs on pharmaceuticals will be ...

Thwarted in her ambition to become a brewmaster, Kiran Mazumdar-Shaw channeled her frustrations into building a knockoff drug ...

If an accused sets up a claim of his false implication on the ground that no sensible person would carry contraband in a ...

his company would be transparent with consumers about the cost of tariffs and broker fees and pass them "directly" on to customers. There would be no way for Cost Plus Drugs to "eat" the costs.